Showing 51-60 of 2123 results for "".
Tax Planning: Common Physician Financial Planning Mistakes: Are You Making One (or Both!)?
https://practicalneurology.com/columns/practice-management/tax-planning-common-physician-financial-planning-mistakes-are-you-making-one-or-both/30543/Improving Your After-Tax Financial Efficiency
https://practicalneurology.com/columns/practice-management/improving-your-after-tax-financial-efficiency/30377/Discontinuing Disease-Modifying Therapy in Multiple Sclerosis: Should You Have an Exit Strategy?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/discontinuing-disease-modifying-therapy-in-multiple-sclerosis-should-you-have-an-exit-strategy/30303/Two experts sound off on the implications of indefinite treatment and whether DMTs should be stopped.Seven Reasons to Review Your Life Insurance Plan
https://practicalneurology.com/columns/practice-management/seven-reasons-to-review-your-life-insurance-plan/30333/Life insurance plans cannot be refinanced like mortgage plans, but they can be replaced.Dementia Caregiver Needs
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-caregiver-needs/31802/Caregiver needs exist and can be addressed at all stages of the dementias.Special Report: 2023 Neurology Drug & Device Approvals
https://practicalneurology.com/diseases-diagnoses/imaging-testing/special-report-2023-neurology-drug-device-approvals/32081/A quick reference for the drugs and devices for neurologic conditions that received approval from the Food and Drug Administration last year.Practical MRI in Neurology: Use Cases, Technologies, and Opportunities for Outpatient Clinics
https://practicalneurology.com/diseases-diagnoses/imaging-testing/practical-mri-in-neurology-use-cases-technologies-and-opportunities-for-outpatient-clinics/56375/The question is no longer whether neurologists should integrate imaging as an extension of the neurologic examination, but how to do so effectively, safely, and sustainably.MS Minute: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/32180/MOGAD, an inflammatory demyelinating disease of the central nervous system, has some overlapping clinical features with NMOSD and MS but is a distinct entity with unique pathologic, clinical, and imaging features.Neuromuscular Notes: Next Generation Treatments for Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-next-generation-treatments-for-myasthenia-gravis/31666/Complement inhibitors, FcRn antagonists, and B-cell targeted therapies increase treatment options for MG but do not replace existing immunosuppressive therapies.Microplastics and "Negative Neuroplasticity": An Emerging Topic in Clinical Neurology
https://practicalneurology.com/columns/practice-management/microplastics-and-negative-neuroplasticity/39811/Microplastics are neurotoxic in nature and can enter and accumulate in the brain, raising many questions concerning their role in common neurologic illnesses.